Table 2.
The carry-over effect of the 1-week early respondersa.
| Characteristics | EA group | SA group | Total | P-value |
|---|---|---|---|---|
| Patients with CSBM response within the first week of treatment | ||||
| Week 8 | 74/90(82.2) | 34/65(52.3) | 108/155(69.7) | <0.001 |
| Week 20 | 61/90(67.8) | 25/65(38.5) | 86/155(55.5) | <0.001 |
|
| ||||
| Patients with CSBM non-response within the first week of treatment | ||||
| Week 8 | 199/428(46.5) | 73/442(16.5) | 272/870(31.3) | <0.001 |
| Week 20 | 160/425(37.7) | 60/441(13.6) | 220/866(25.4) | <0.001 |
aThe number of patients with CSBM response and nonresponse within the first week of treatment are derived from Table 1.